Completed
Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
NCT01585207
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Tics and Tourette's Clinical and Research Program New York, United States